Byoung Ok Ahn

531 total citations
25 papers, 464 citations indexed

About

Byoung Ok Ahn is a scholar working on Molecular Biology, Psychiatry and Mental health and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Byoung Ok Ahn has authored 25 papers receiving a total of 464 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 7 papers in Psychiatry and Mental health and 6 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Byoung Ok Ahn's work include Sexual function and dysfunction studies (7 papers), Hormonal and reproductive studies (5 papers) and Pharmacological Effects of Natural Compounds (4 papers). Byoung Ok Ahn is often cited by papers focused on Sexual function and dysfunction studies (7 papers), Hormonal and reproductive studies (5 papers) and Pharmacological Effects of Natural Compounds (4 papers). Byoung Ok Ahn collaborates with scholars based in South Korea. Byoung Ok Ahn's co-authors include Kyung Koo Kang, Tae Young Oh, Won Bae Kim, Moohi Yoo, Seul Min Choi, Soon Hoe Kim, Eun Bang Lee, Keùn Huh, Jung-Ae Kim and Sung Keun Kang and has published in prestigious journals such as The Journal of Urology, European Urology and Journal of Ethnopharmacology.

In The Last Decade

Byoung Ok Ahn

23 papers receiving 451 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Byoung Ok Ahn South Korea 12 125 107 106 66 61 25 464
Soon Hoe Kim South Korea 12 107 0.9× 108 1.0× 135 1.3× 62 0.9× 44 0.7× 18 385
Taotao Sun China 12 122 1.0× 137 1.3× 110 1.0× 39 0.6× 51 0.8× 42 440
Abdullah Sivrikaya Türkiye 13 121 1.0× 37 0.3× 77 0.7× 31 0.5× 41 0.7× 67 604
Burak Cem Soner Türkiye 12 117 0.9× 40 0.4× 38 0.4× 34 0.5× 42 0.7× 30 433
Delminda Neves Portugal 15 121 1.0× 100 0.9× 191 1.8× 9 0.1× 26 0.4× 57 555
Claudia Baraldi Italy 13 98 0.8× 48 0.4× 29 0.3× 29 0.4× 22 0.4× 22 378
Lucio Bianchi Italy 15 184 1.5× 17 0.2× 279 2.6× 71 1.1× 189 3.1× 23 634
Canan Küçükgergin Türkiye 17 155 1.2× 15 0.1× 64 0.6× 26 0.4× 25 0.4× 49 704
Suman Patel United States 11 107 0.9× 28 0.3× 63 0.6× 18 0.3× 36 0.6× 28 396
Dong‐Il Kim South Korea 17 208 1.7× 15 0.1× 121 1.1× 67 1.0× 183 3.0× 101 816

Countries citing papers authored by Byoung Ok Ahn

Since Specialization
Citations

This map shows the geographic impact of Byoung Ok Ahn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Byoung Ok Ahn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Byoung Ok Ahn more than expected).

Fields of papers citing papers by Byoung Ok Ahn

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Byoung Ok Ahn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Byoung Ok Ahn. The network helps show where Byoung Ok Ahn may publish in the future.

Co-authorship network of co-authors of Byoung Ok Ahn

This figure shows the co-authorship network connecting the top 25 collaborators of Byoung Ok Ahn. A scholar is included among the top collaborators of Byoung Ok Ahn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Byoung Ok Ahn. Byoung Ok Ahn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Choi, Seul Min, et al.. (2012). Protective effects of acetyl-L-carnitine on neurodegenarative changes in chronic cerebral ischemia models and learning-memory impairment in aged rats. Archives of Pharmacal Research. 35(1). 145–154. 16 indexed citations
2.
Kim, Young‐Woo, Woo Hyung Lee, Seul Min Choi, et al.. (2011). DA6034 promotes gastric epithelial cell migration and wound‐healing through the mTOR pathway. Journal of Gastroenterology and Hepatology. 27(2). 397–405. 33 indexed citations
3.
Choi, Seul Min, et al.. (2011). Effects of DA-6034, a Flavonoid Derivative, on Mucin-like Glycoprotein and Ocular Surface Integrity in a Rabbit Model. Arzneimittelforschung. 59(10). 498–503. 8 indexed citations
4.
Choi, Seul Min, et al.. (2009). Effects of DA-6034 on Aqueous Tear Fluid Secretion and Conjunctival Goblet Cell Proliferation. Journal of Ocular Pharmacology and Therapeutics. 25(3). 209–214. 10 indexed citations
5.
Choi, Seul Min, et al.. (2009). Beneficial effects of the combination of amlodipine and losartan for lowering blood pressure in spontaneously hypertensive rats. Archives of Pharmacal Research. 32(3). 353–358. 10 indexed citations
6.
7.
Choi, Seul Min, et al.. (2007). Gastroprotective Effects of DA-6034, a New Flavonoid Derivative, in Various Gastric Mucosal Damage Models. Digestive Diseases and Sciences. 52(11). 3075–3080. 43 indexed citations
8.
Choi, Seul Min, Kyung Koo Kang, Byoung Ok Ahn, et al.. (2005). Chronic administration of phosphodiesterase 5 inhibitor improves erectile and endothelial function in a rat model of diabetes. International Journal of Andrology. 28(5). 260–266. 32 indexed citations
9.
Choi, Seul Min, et al.. (2005). DA-9201 shows anti-asthmatic effects by suppressing NF-кB expression in an ovalbumin-lnduced mouse model of asthma. Archives of Pharmacal Research. 28(12). 1350–1357. 4 indexed citations
10.
Kang, Kyung Koo, Dong Sung Kim, Byoung Ok Ahn, et al.. (2005). DA-8159 reverses selective serotonin reuptake inhibitor-induced erectile dysfunction in rats. Urology. 65(1). 202–207. 17 indexed citations
11.
Shim, Hyun Joo, Dong Kim, Kyung Koo Kang, et al.. (2003). Subacute toxicities and toxicokinetics of DA‐8159, a new phosphodiesterase type V inhibitor, after single and 4‐Week repeated oral administration in rats. Biopharmaceutics & Drug Disposition. 24(9). 409–418. 8 indexed citations
12.
Kang, Kyung Koo, et al.. (2003). DA-8159, a potent cGMP phosphodiesterase inhibitor, attenuates monocrotaline-induced pulmonary hypertension in rats. Archives of Pharmacal Research. 26(8). 612–619. 8 indexed citations
13.
Kang, Kyung Koo, et al.. (2003). DA-8159, a new PDE5 Inhibitor, Induces Penile Erection in Conscious and Acute Spinal Cord Injured Rabbits. European Urology. 43(6). 689–695. 26 indexed citations
14.
Huh, Keùn, et al.. (2003). Inhibitory effects of DA-9601 on ethanol-induced gastrohemorrhagic lesions and gastric xanthine oxidase activity in rats. Journal of Ethnopharmacology. 88(2-3). 269–273. 55 indexed citations
15.
Seo, Kwang‐Suk, et al.. (2002). Effect of recombinant human fsh on ovulation, pregnancy andIn Vitro fertilization in androgen-sterilized mice. Archives of Pharmacal Research. 25(3). 357–363. 3 indexed citations
16.
Oh, Tae Young, Kyung Koo Kang, Byoung Ok Ahn, Moohi Yoo, & Won Bae Kim. (2000). Erectogenic effect of the selective phosphodiesterase type 5 inhibitor, DA-8159. Archives of Pharmacal Research. 23(5). 471–476. 38 indexed citations
17.
Kim, Dong Hwan, et al.. (1999). Acute Toxicity Study on Recombinant Human Basic Fibroblast Growth Factor in Rats and Dogs. Toxicological Research. 15(2). 211–214. 1 indexed citations
18.
Ahn, Byoung Ok, et al.. (1999). Four-week Repeated Dose Toxicity Study of Recombinant Human Basic Fibroblast Growth Factor by Subcutaneous Administration in Rats. Toxicological Research. 15(2). 215–226. 1 indexed citations
19.
Ahn, Byoung Ok, et al.. (1998). Studies on protective effect of DA-9601,Artemisia asiatica extract, on acetaminophen- and CCI4-induced liver damage in rats. Archives of Pharmacal Research. 21(5). 508–513. 56 indexed citations
20.
Oh, Tae Young, Byoung Ok Ahn, Soon Hoe Kim, et al.. (1997). Protective effect of DA-9601, an extract ofArtemisiae Herba, against naproxen-induced gastric damage in arthritic rats. Archives of Pharmacal Research. 20(5). 414–419. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Soon Hoe Kim Breakdown of academic impact, for papers by Taotao Sun Breakdown of academic impact, for papers by Abdullah Sivrikaya Breakdown of academic impact, for papers by Burak Cem Soner Breakdown of academic impact, for papers by Delminda Neves Breakdown of academic impact, for papers by Claudia Baraldi Breakdown of academic impact, for papers by Lucio Bianchi Breakdown of academic impact, for papers by Canan Küçükgergin Breakdown of academic impact, for papers by Suman Patel Breakdown of academic impact, for papers by Dong‐Il Kim
Rankless by CCL
2026